Cost-effectiveness analysis of second intravenous immunoglobulin infusion versus infliximab for treating IVIG-resistant Kawasaki disease patients

Abstract Objective Intravenous immunoglobulin (IVIG) is a known effective treatment to reduce the incidence of coronary artery aneurysms in Kawasaki disease (KD) patients. However, there has been an increase in IVIG-resistant patients and a lack of clinical trial data to determine the best second tr...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jada M. Johnson, Kit N. Simpson, Annie N. Simpson, Adriana H. Tremoulet, Jane C. Burns
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2025-11-01
coleção:	Cost Effectiveness and Resource Allocation
Assuntos:	Pediatrics Persistent fever ICER Comparative effectiveness Coronary artery aneurysm Blood transfusion
Acesso em linha:	https://doi.org/10.1186/s12962-025-00674-0
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!